AlexandriaPhanMD

PubMed

• 3 citations
  A qualitative study to understand the experience of somatostatin analog treatments from the perspective of patients with neuroendocrine tumors.
  Caroline Seo, Erica Horodniceanu, Rachel Shah, Grace Goldstein, David Ray, Bonita Bennett, Alexandria Phan, Kelly McCarrier> ;Supportive Care in Cancer. 2022 Jul 1
• 7 citations
  Neuroendocrine Tumors: a Relevant Clinical Update.
  Emma N Rizen, Alexandria T Phan> ;Current Oncology Reports. 2022 Jun 1
• 1 citations
  Exploration of machine learning techniques to examine the journey to neuroendocrine tumor diagnosis with real-world data.
  Nicole M. Zimmerman, David Ray, Nicole Princic, Meghan Moynihan, Callisia N. Clarke, Alexandria T Phan> ;Future Oncology. 2021 May 19
• 27 citations
  Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study.
  Martyn Caplin, Marianne Pavel, Alexandria T. Phan, Jarosław B. Ćwikła, Eva Sedlackova, Xuan-Mai Truong Thanh, Edward M. Wolin, Philippe Ruszniewski, Clarinet Investiga...> ;Endocrine. 2021 Feb 1
• 10 citations
  Epidemiological risk factors for adrenocortical carcinoma: A hospital-based case-control study.
  Mouhammed Amir Habra, Mohamad Anas Sukkari, Youssef Albousen, Mohamed A Elsheshtawi, Camilo Jimenez, Matthew Campbell, Jose A. Karam, Paul H. Graham, Rikita Hatia, Ale...> ;International Journal of Cancer. 2020 Apr 1
• 4 citations
  Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors.
  Tal Grenader, Marianne Pavel, Philippe Ruszniewski, Jarosław B. Ćwikła, Alexandria T Phan, Markus Raderer, Eva Sedlackova, Guillaume Cadiot, Edward M. Wolin, Jaume Cap...> ;Anti-Cancer Drugs. 2020 Mar 1
• 23 citations
  Immunotherapy and targeted therapy-the new roadmap in cancer treatment.
  Kamran Shahid, Mustafa Khalife, Raetasha S Dabney, Alexandria T Phan> ;Annals of Translational Medicine. 2019 Dec 6
• 11 citations
  Molecular pathways and targeted therapy in cholangiocarcinoma.
  Raetasha S Dabney, Mustapha Khalife, Kamran Shahid, Alexandria T Phan> ;Clinical Advances in Hematology & Oncology. 2019 Nov 1
• 5 citations
  Patterns of Care Among Real-World Patients with Metastatic Neuroendocrine Tumors.
  Andrew J Klink, Bruce A. Feinberg, Hsing-Ting Yu, David Ray, Sonia Pulgar, Alexandria T. Phan, Aaron I. Vinik> ;The Oncologist. 2019 Oct 1
• 3 citations
  Stereotactic body radiation therapy and immunotherapy.
  Mustapha Khalife, Kamran Shahid, Raetasha S Dabney, Alexandria T Phan> ;Clinical Advances in Hematology & Oncology. 2019 Sep 1
• 9 citations
  Effect of Lanreotide Depot/Autogel on Urinary 5‐Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocri...
  Marianne Pavel, Alexandria T. Phan, Edward M. Wolin, Beloo Mirakhur, Nilani Liyanage, Susan Pitman Lowenthal, George A. Fisher, Aaron I. Vinik> ;The Oncologist. 2019 Apr 1
• 4 citations
  BIOCHEMICAL RESPONSES IN SYMPTOMATIC AND ASYMPTOMATIC PATIENTS WITH NEUROENDOCRINE TUMORS: POOLED ANALYSIS OF TWO PHASE 3 TRIALS
  Beloo Mirakhur, Marianne Pavel, Rodney F. Pommier, George A. Fisher, Alexandria T. Phan, Christine Massien, Nilani Liyanage, Susan Pitman Lowenthal, Aaron I. Vinik> ;Endocrine Practice. 2018 Aug 7
• 10 citations
  Two birds, one stone: hesperetin alleviates chemotherapy-induced diarrhea and potentiates tumor inhibition
  Yaping Yu, Ren Kong, Huojun Cao, Zheng Yin, Jiyong Liu, Xiang Nan, Alexandria T. Phan, Tian Ding, Hong Zhao, Stephen T. C. Wong> ;Oncotarget. 2018 Feb 23
• 63 citations
  Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma
  Manal Hassan, Gehan Botrus, Reham Abdel-Wahab, Robert A. Wolff, Donghui Li, David J. Tweardy, Alexandria T. Phan, Ernest T. Hawk, Milind Javle, Ju Seog Lee, Harrys A. ...> ;Clinical Gastroenterology and Hepatology. 2017 Nov 1
• 25 citations
  Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis - a retrospective study from a tertiary center.
  Xinyu Nan, Qian Qin, Cesar Gentille, Joe Ensor, Christopher Leveque, Sai Ravi Pingali, Alexandria T. Phan, Lawrence Rice, Swaminathan P. Iyer> ;Leukemia & Lymphoma. 2017 Jan 31
• 4 citations
  Neuroendocrine Tumors and Lanreotide Depot: Clinical Considerations and Nurse and Patient Preferences.
  Pamela Ryan, Alexandria T. Phan, Daphne T. Adelman, Michiko Iwasaki> ;Clinical Journal of Oncology Nursing. 2016 Dec 1
• 11 citations
  The pivotal role of mammalian target of rapamycin inhibition in the treatment of patients with neuroendocrine tumors.
  Alexandria T. Phan, Bhuvanesh Dave> ;Cancer Medicine. 2016 Oct 1
• 15 citations
  Lanreotide Depot: An Antineoplastic Treatment of Carcinoid or Neuroendocrine Tumors
  Edward M. Wolin, Amandine Manon, Christophe Chassaing, Andrew L. Lewis, Laurent Bertocchi, Joël Richard, Alexandria T. Phan> ;Journal of Gastrointestinal Cancer. 2016 Dec 1
• Palmoplantar psoriasis, a frequent and severe clinical type of psoriasis in children.
  Amode R, Hadj-Rabia S, Bursztejn A, Phan A, Boralevi F, Droitcourt C, Mazereeuw-Hautier J, Piram M, Plantin P, Absaq C, Lasek-Duriez A, Balguierie X, Maruani A, Beauch...> ;J Eur Acad Dermatol Venereol. 2016-08-01
• 16 citations
  Next-Generation Sequencing of Matched Primary and Metastatic Rectal Adenocarcinomas Demonstrates Minimal Mutation Gain and Concordance to Colonic Adenocarcinomas.
  Suzanne M. Crumley, Kristi Pepper, Alexandria T. Phan, Randall J. Olsen, Mary R. Schwartz, Bryce P. Portier> ;Archives of Pathology & Laboratory Medicine. 2016 Jun 1
• Systemic treatments in childhood psoriasis: a French multicentre study on 154 children.
  Charbit L, Mahé E, Phan A, Chiaverini C, Boralevi F, Bourrat E, Lasek A, Maruani A, Aubin F, Droitcourt C, Barbarot S, Mallet S, Mazereeuw-Hautier J, Begon E, Abasq C,...> ;Br. J. Dermatol.. 2016-05-01
• 162 citations
  Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: The CLARINET open-label extension study
  Martyn Caplin, Marianne Pavel, Jarosław B. Ćwikła, Alexandria T. Phan, Markus Raderer, Eva Sedlackova, Guillaume Cadiot, Edward M. Wolin, Jaume Capdevila, Lucy Wall, G...> ;Endocrine-Related Cancer. 2016 Mar 1
• 8 citations
  A Phase I/II Study of Docetaxel, Oxaliplatin, and Fluorouracil (D-FOX) Chemotherapy in Patients with Untreated Locally Unresectable or Metastatic Adenocarcinoma of the...
  Mariela A. Blum Murphy, Wei Qiao, Nishith Mewada, Roopma Wadhwa, Elena Elimova, Taketa Takashi, Linus Ho, Alexandria T. Phan, Jackie Baker, Jaffer A. Ajani> ;American Journal of Clinical Oncology. 2016 Feb 22
• The BRAAFF checklist: a new dermoscopic algorithm for diagnosing acral melanoma.
  Lallas A, Kyrgidis A, Koga H, Moscarella E, Tschandl P, Apalla Z, Di Stefani A, Ioannides D, Kittler H, Kobayashi K, Lazaridou E, Longo C, Phan A, Saida T, Tanaka M, T...> ;Br. J. Dermatol.. 2015-10-01
• 6 citations
  A Comparison between Appendiceal and Nonappendiceal Neuroendocrine Tumors in Children and Young Adults: A Single-institution Experience
  Catherine H. Boston, Alexandria T. Phan, Mark F. Munsell, Cynthia E. Herzog, Winston W. Huh> ;Journal of Pediatric Hematology/oncology. 2015 Aug 6
• Join now to see all

Books/Book Chapters

• M D Anderson Cancer Center 100 years of History 
  Chapter: Gastric Cancer 
  Phan AT, Mansfield PEditors: Rodriguez A, Burke T.McGraw-Hill2013
• Neuroendocrine Tumors 
  Chapter: Adrenocortical carcinoma 
  Phan AT and Jimenez CEditors: Yao JC.Springer2011
• Oncologic Imaging 
  Chapter: Gastric Carcinoma 
  Vikram R, Patnana M, Devine K, Mansfield P, Phan ATEditors: Silverman PM.Elsevier2011
• Targeted Therapy in the Age of Personalized Cancer Care 
  Chapter: Targeted Therapy for Endocrine Neoplasms 
  Garg R, Agrawal M, Quintas-Cardama A, Phan ATEditors: Qintas-Cardaman A, Cataldo V, Gibbons D.Nova Science2011
• MD Anderson Manual of Clinical 
  Chapter: Carcinoma of the Esophagus and Gastric 
  Phan AT, Valero VEditors: Kantarjian H, Wolff RA, Koller C.McGraw-Hill2005
• Chemoradiation in Cancer Therapy 
  Chapter: Chapter 13-Combined Modality Therapy in Gastric, Pancreatic, and Biliary Tract Carcinomas 
  Phan AT, Ajani JAEditors: Hak Choy.Humana Press2003
• Join now to see all

Abstracts/Posters

• Risk of anxiety/depression events in patients newly diagnosed with neuroendocrine tumors
  C. Chen, G.P. Hess, Z. Liu, J.C. Yao, A.T. Phan, J.W. Hill, ASCO, 1/1/2011
• Risk of osteoporosis/osteopenia events in patients newly diagnosed with neuroendocrine tumors
  J.W. Hill, C. Chen, G.P. Hess, Z. Liu, J.C. Yao, A.T. Pha, ASCO, 1/1/2011
• Neuroendocrine tumor disease state and PROMIS health-related quality of life scores
  Cella D, Beaumont JL, Liu Z, Phan AT, Choi S, Yao JC, ASCO, 1/1/2010
• Relationship between neuroendocrine tumor-related symptoms and health-related quality of life
  Beaumont JL, Liu Z, Choi S, Yao JC, Phan AT, Cella D, ASCO GI, 1/1/2010
• Somatostatin analogue therapy and PROMIS health-related quality-of-life scores in patients with neuroendocrine tumors
  M. Dong, J.L. Beaumont, Z. Liu, A.T. Phan, S. Choi, D. Cella, J.C. Yao, ASCO, 1/1/2010
• A prospective, multi-institutional phase II study of GW786034 (pazopanib) and depot octreotide (sandostatin LAR) in advanced low-grade neuroendocrine carcinoma (LGNEC)
  Phan AT, Yao JC, Fogleman D, Hess KR, Ng CS, Bullock SA, Malinowski P, Regan E, Kulke M, ASCO, 1/1/2010
• Neuroendocrine tumor disease state and health-related quality of life
  Phan AT, Beaumont JL, Liu Z, Choi S, Cella D, Yao JC, ASCO GI, 1/1/2010
• Phase II study of telatinib (T) in combination with capecitabine (X) and cisplatin (P) as first-line treatment in patients (pts) with advanced cancer of the stomach (G...
  Ko AH, Tabernero J, Garcia De Paredes M, Rivera F, Schnell FM, Baker JS. Phan AT, Alsina M, Patel K, Ajani JA, ASCO, 1/1/2010
• Association of neoadjuvant chemoradiation with improved survival in resectable gastric cancer
  Bose D., Badgwell B., Cormier J. N., Wen S, Yao J. C., Staerkel G. A., Crane C. H., Pisters P. W., Phan A., Mansfield P. F, GI ASCO, 1/1/2009
• A phase I pharmacokinetic (PK) study of MBP-426, a novel liposome encapsulated oxaliplatin
  Sankhala K. K., Mita A. C., Adinin R., Wood L., Beeram M., Bullock S., Yamagata N., Matsuno K., Fujisawa T., Phan A, ASCO, 1/1/2009
• A phase II study of irinotecan and cisplatin for metastatic or unresectable high grade neuroendocrine carcinoma
  Mani MA, Shroff RT, Jacobs C, Wolff RA, Ajani JA, Yao JC, Phan AT, ASCO, 1/1/2008
• The pharmacokinetics and pharmacodynamics of IMGN242 (huC242-DM4) in patients with CanAg-expressing solid tumors
  Qin A, Watermill J, Mastico RA, Lutz RJ, O’Keeffe J, Zildjian S, Mita AC, Phan AT, Tolcher AW, ASCO, 1/1/2008
• Phase I/II trial of docetaxel plus oxaliplatin and 5-fluorouracil (D-FOX) in patients with untreated, advanced gastric or gastroesophageal cancer
  Ajani JA, Phan AT, Ho L, Tetzlaff ED, Baker J, Wei Q, ASCO, 1/1/2007
• Phase II study of RAD001 and Depot Octreotide in patients with advanced low
  Phan AT, Chang DZ, Rashid A, Meric-Bernstam F, Yao JC, 8th World Congress on Gastrointestinal Cancer, 6/1/2006
• Phase I/II trial of capecitabine (C), dacarbazine (D) and imatinib (I) (CDI) for patients (pts) metastatic medullary thyroid carcinomas (MTC)
  Hoff PM, Hoff AO, Phan AT, Sherman SI, Yao JC, White N, Phan L, Abbruzzese JL, Gagel RF, ASCO, 1/1/2006
• Association of VEGF expression with poor prognosis among patients with low-grade neuroendocrine carcinoma
  Phan AT, Wang L, Xie K, Zhang J, Rashid A, Evans D, Vauthey J, Abdalla E, Abbruzzese JL, Yao JC, ASCO, 1/1/2006
• Join now to see all

Lectures

• Management of NET & Adrenal Cancers 
  1/1/2012
• Management of Advanced Gastric Cancer 
  1/1/2007
• Advances Management of Upper GI Cancers 
  1/1/2006
• Management of Adrenal Cancers 
  1/1/2004
• Join now to see all